Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype

Molecules and Cells

Volumn 36, Issue 4, 2013, Pages 368-375

  Yang, Wook Jin ^a   Song, Min Ji ^a   Park, Eun Young ^b   Lee, Jong Joo ^a   Park, Joo Hong ^a   Park, Keunhee ^a   Park, Jong Hoon ^b   Kim, Hyoung Pyo ^a  

^a Yonsei University   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

ABCG2; chemoresistance; side population; Sp1; Sp3; transcription

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; MITHRAMYCIN; MITHRAMYCIN A; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL VIABILITY; CHEMOSENSITIZATION; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; PHENOTYPE; PROMOTER REGION; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; CELL LINE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PLICAMYCIN; PROMOTER REGIONS, GENETIC; SIDE-POPULATION CELLS; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

EID: 84888432948     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-0191-x     Document Type: Article

References (30)

1. Allikmets, R., Schriml, L.M., Hutchinson, A., Romano-Spica, V., and Dean, M. (1998). A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58, 5337-5339.
2. Bailey-Dell, K.J., Hassel, B., Doyle, L.A., and Ross, D.D. (2001). Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim. Biophys. Acta 1520, 234-241.
3. Bunting, K.D. (2002). ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20, 11-20.
4. Chen, Y.J., Huang, W.C., Wei, Y.L., Hsu, S.C., Yuan, P., Lin, H.Y., Wistuba, II, Lee, J.J., Yen, C.J., Su, W.C., et al. (2011). Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells. PLoS One 6, e21428.
5. Dalerba, P., Cho, R.W., and Clarke, M.F. (2007). Cancer stem cells: models and concepts. Ann. Rev. Med. 58, 267-284.
6. Doyle, L.A., Yang, W., Abruzzo, L.V., Krogmann, T., Gao, Y., Rishi, A.K., and Ross, D.D. (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95, 15665-15670.
7. Ee, P.L., Kamalakaran, S., Tonetti, D., He, X., Ross, D.D., and Beck, W.T. (2004). Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64, 1247-1251.
8. Fischer, B., Frei, C., Moura, U., Stahel, R., and Felley-Bosco, E. (2012). Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer 78, 23-29.
9. Goodell, M.A., McKinney-Freeman, S., and Camargo, F.D. (2005). Isolation and characterization of side population cells. Methods Mol. Biol. 290, 343-352.
10. Hamada, S., Satoh, K., Hirota, M., Kanno, A., Umino, J., Ito, H., Masamune, A., Kikuta, K., Kume, K., and Shimosegawa, T. (2012). The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. J. Cell. Physiol. 227, 729-738.
11. Hirschmann-Jax, C., Foster, A.E., Wulf, G.G., Nuchtern, J.G., Jax, T.W., Gobel, U., Goodell, M.A., and Brenner, M.K. (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101, 14228-14233.
12. Ho, M.M., Ng, A.V., Lam, S., and Hung, J.Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67, 4827-4833.
13. Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., and Sugimoto, Y. (2002). Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int. J. Cancer 97, 626-630.
14. Krishnamurthy, P., Ross, D.D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K.E., Sarkadi, B., Sorrentino, B.P., and Schuetz, J.D. (2004). The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218-24225.
15. Lee, J.J., Park, K., Shin, M.H., Yang, W.J., Song, M.J., Park, J.H., Yong, T.S., Kim, E.K., and Kim, H.P. (2011). Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression. Biochem. Biophys. Res. Commun. 409, 222-228.
16. Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T., et al. (1999). Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59, 8-13.
17. Mo, W., and Zhang, J.T. (2012). Human ABCG2: structure, function, and its role in multidrug resistance. Int. J. Biochem. Mol. Biol. 3, 1-27.
18. Pan, Y.Z., Morris, M.E., and Yu, A.M. (2009). MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol. Pharmacol. 75, 1374-1379.
19. Safe, S., and Abdelrahim, M. (2005). Sp transcription factor family and its role in cancer. Eur. J. Cancer 41, 2438-2448.
20. Scharenberg, C.W., Harkey, M.A., and Torok-Storb, B. (2002). The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99, 507-512.
21. Szatmari, I., Vamosi, G., Brazda, P., Balint, B.L., Benko, S., Szeles, L., Jeney, V., Ozvegy-Laczka, C., Szanto, A., Barta, E., et al. (2006). Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem. 281, 23812-23823.
22. To, K.K., Zhan, Z., and Bates, S.E. (2006). Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol. Cell. Biol. 26, 8572-8585.
23. To, K.K., Polgar, O., Huff, L.M., Morisaki, K., and Bates, S.E. (2008). Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol. Cancer Res. 6, 151-164.
24. To, K.K., Robey, R.W., Knutsen, T., Zhan, Z., Ried, T., and Bates, S.E. (2009). Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol. Cancer Ther. 8, 2959-2968.
25. Turner, J.G., Gump, J.L., Zhang, C., Cook, J.M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M.J., Dalton, W.S., and Sullivan, D.M. (2006). ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood 108, 3881-3889.
26. Wang, F., Xue, X., Wei, J., An, Y., Yao, J., Cai, H., Wu, J., Dai, C., Qian, Z., Xu, Z., et al. (2010). hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br. J. Cancer 103, 567-574.
27. Xu, J., Peng, H., Chen, Q., Liu, Y., Dong, Z., and Zhang, J.T. (2007). Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity. Cancer Res. 67, 4373-4381.
28. Yuan, C., Yang, M.C., Zins, E.J., Boehlke, C.S., and Huang, A.J. (2004). Identification of the promoter region of the human betaIGH3 gene. Mol. Vision 10, 351-360.
29. Zhang, M., Mathur, A., Zhang, Y., Xi, S., Atay, S., Hong, J.A., Datrice, N., Upham, T., Kemp, C.D., Ripley, R.T., et al. (2012). Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells. Cancer Res. 72, 4178-4192.
30. Zhou, S., Schuetz, J.D., Bunting, K.D., Colapietro, A.M., Sampath, J., Morris, J.J., Lagutina, I., Grosveld, G.C., Osawa, M., Nakauchi, H., et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028-1034.